Vicarious Surgical (NYSE:RBOT) Trading Up 1.5% – Still a Buy?

Vicarious Surgical Inc (NYSE:RBOT) shares were up 1.5% on Friday . The company traded as high as $6.47 and last traded at $6.42. Approximately 4,313 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 25,833 shares. The stock had previously closed at $6.32.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. Morgan Stanley lowered their target price on shares of Vicarious Surgical from $18.00 to $10.00 and set an “equal weight” rating on the stock in a research note on Monday, July 15th. Piper Sandler dropped their price objective on Vicarious Surgical from $30.00 to $12.00 and set a “neutral” rating on the stock in a report on Tuesday, August 13th.

Vicarious Surgical Trading Up 1.4 %

The stock has a market cap of $37.82 million, a price-to-earnings ratio of -0.62 and a beta of 1.12. The firm’s 50-day moving average is $5.98 and its two-hundred day moving average is $7.70.

Vicarious Surgical (NYSE:RBOT) last announced its earnings results on Monday, August 12th. The company reported ($2.86) EPS for the quarter, beating analysts’ consensus estimates of ($2.98) by $0.12. On average, analysts predict that Vicarious Surgical Inc will post -10.07 earnings per share for the current year.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.